Market Research Food & Beverage Market Research Food Market Research Functional Foods & Beverages Market Research

Human Microbiome Market Forecasts to 2030 – Global Analysis By Product (Medical Foods, Prebiotics, Probiotics, Symboitics and Other Products), Disease, Type, Application and By Geography

Best Price Guarantee Length Publisher Published Date SKU
from $4,150 200 Pages Stratistics Market Research Consulting November, 2023 SMR18332649
Best Price Guarantee
Price from $4,150
Length 200 Pages
Publisher Stratistics Market Research Consulting
Published Date November, 2023
SKU SMR18332649

Human Microbiome Market Forecasts to 2030 – Global Analysis By Product (Medical Foods, Prebiotics, Probiotics, Symboitics and Other Products), Disease, Type, Application and By Geography


According to Stratistics MRC, the Global Human Microbiome Market is accounted for $0.8 billion in 2023 and is expected to reach $6.3 billion by 2030 growing at a CAGR of 34.1% during the forecast period. The term ""Human Microbiomes Market"" defines the area of biotechnology and healthcare that focuses on the thorough study, analysis, and commercial applications of the human microbiome, which is the enormous and diverse community of microorganisms that exists both inside and outside the human body. To comprehend the symbiotic interaction between the human body and its resident microorganisms, it comprises a variety of fields, including research, diagnostics, treatments, and customized medicine.

According to the American Cancer Society, 2022 estimates, there are about 1,918,030 new cases of cancer will be reported in the United States in 2022. Additionally, according to the Globocan 2020 statistics, there are 274,364 new cases of cancer and is expected to reach 400,564 new cases by 2040.

Market Dynamics:

Driver:

Research advances in the microbiome

An enormous shift has occurred in the comprehension of the human microbiome's involvement in human health and disease as a result of the substantial advancements made in the investigation of it over the past few decades. Additionally, the tremendous community of microorganisms that reside inside the human body has been thoroughly analyzed and characterized because of high-throughput sequencing methods and powerful bioinformatics tools.

Restraint:

Regulatory barriers

The lack of transparent and uniform regulatory processes for microbiome-based products and treatments is one of the main problems. The absence of simple and uniform regulatory frameworks for microbiome-based products and treatments may limit market expansion and increase entry hurdles. However, the variety of microbial communities and the dynamic nature of the human microbiome present difficulties for regulatory authorities when evaluating products' safety and efficacy.

Opportunity:

Chronic disease prevalence is on the rise

Globally, chronic illnesses such as obesity, diabetes, inflammatory bowel diseases, and autoimmune disorders are becoming more prevalent. As a result, in order to better understand and manage these chronic diseases, medical professionals and academics are exploring microbiome-based therapies. Additionally, the restoration of microbial equilibrium among individuals with chronic illnesses involves a number of developing methods, including probiotics, fecal microbiota transplantation (FMT), and microbiome regulation.

Threat:

Research and development expenses

In order to fully comprehend the complexity of the human microbiome as well as develop products and eliminates that are based on it, the field of microbiome research requires significant investments in research and development (R&D). The creation of microbiome therapies like probiotics and prebiotics, as well as data analysis, clinical trials, and microbiome sequencing, are all included in these expenditures. However, the variety of products and treatments available may be hampered by the high cost of R&D, which may prevent smaller businesses and startups from entering the market.

Covid-19 Impact:

Clinical trial research has been significantly hampered worldwide by the COVID-19 epidemic. Given that studies usually include poor people who are most in danger from COVID-19 exposure, this is very important. Similarly, COVID-19 has had a detrimental effect and might still have one on the operations of other companies, including their preclinical research and clinical testing of microbiome-based drugs and diagnostic instruments.

The probiotics segment is expected to be the largest during the forecast period

The segment for probiotics is anticipated to be the largest during the forecast period. Probiotics are living microorganisms that, when administered to a host in sufficient proportions, improve or maintain the host's overall health by restoring or maintaining their intestinal microbiome. Due to their significance in promoting immune health, boosting digestion, and potentially affecting a number of different elements of general wellbeing, they have grown tremendously popular. Furthermore, with an increasing emphasis on preventive health and wellness, the probiotics sector is anticipated to develop as customers look for microbiome-friendly remedies to their medical issues.

The diagnostics segment is expected to have the highest CAGR during the forecast period

Due to the growing awareness of the crucial role played by the human microbiome in health and illness, the diagnostics segment is anticipated to have the highest growth rate throughout the projection period. Microbiome diagnostics can offer a deeper comprehension of the microbial populations within the body due to developments in sequencing technologies and bioinformatics, enabling personalized and precise therapy. Moreover, microbiome diagnostics are also becoming more popular in healthcare due to their potential to support early disease detection, guide individualized treatment strategies, and assess the success of interventions.

Region with largest share:

North America held the largest share due to an established network of healthcare facilities, greater investment from major firms in developing more advanced technology, accelerating the process of creating new drugs, and a rise in research efforts in this field. Additionally, human microbiome treatments are getting more attention, lifestyle ailments are becoming more prevalent, and next-generation sequencing and the human microbiome are experiencing more technological advancements. These factors are all contributing to the market's growth in the region.

Region with highest CAGR:

Due to growing consumer interest in probiotics, prebiotics, and microbiome-focused products, the Asia-Pacific area is predicted to experience profitable growth. This is due to digestion, nutritional wellness, and the importance of the microbiome in overall well-being which are becoming more widely recognized. Additionally, the Asia Pacific area has experienced a rise in research and development activities in the field of microbiome science, especially in nations like China, Japan, and South Korea that have made significant investments in biotechnology and the life sciences.

Key players in the market

Some of the key players in Human Microbiome market include Seres Therapeutics, Second Genome Inc., Osel Inc., Exeliom Biosciences SAS, Ginkgo Bioworks, Finch Therapeutics Group Inc., Evelo Biosciences Inc, DuPont, Axial Biotherapeutics, Inc. and Astarte Medical.

Key Developments:

In January 2023, Genetic Analysis AS, a research driven diagnostic company that focuses on innovative diagnostic solutions with microbiota analysis, entered into an agreement with Microbiome Research Pvt. Ltd., a India-based microbiome company, for launching a test service portfolio based on the GA-map Dysbiosis Test, and thus, making it the first CE-IVD marked standardized gut microbiome test.

In May 2022, 4D Pharma, a global pharmaceutical company that develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis, announced clinical trial for MRx0518 with combination bavencio, a PD – L1 blocking antibody indicated for the treatment of urothelial cancer

Products Covered:
• Medical Foods
• Prebiotics
• Probiotics
• Symboitics
• Other Products

Diseases Covered:
• Metabolic
• Endocrine
• Infectious

Types Covered:
• Cancer
• Metabolic and Gastrointestinal Disorders
• Autoimmune Disorder
• Obesity
• Other Types

Applications Covered:
• Diagnostics
• Therapeutics
• Other Applications

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Human Microbiome Market, By Product
5.1 Introduction
5.2 Medical Foods
5.3 Prebiotics
5.4 Probiotics
5.5 Symboitics
5.6 Other Products
6 Global Human Microbiome Market, By Disease
6.1 Introduction
6.2 Metabolic
6.3 Endocrine
6.4 Infectious
7 Global Human Microbiome Market, By Type
7.1 Introduction
7.2 Cancer
7.3 Metabolic and Gastrointestinal Disorders
7.4 Autoimmune Disorder
7.5 Obesity
7.6 Other Types
8 Global Human Microbiome Market, By Application
8.1 Introduction
8.2 Diagnostics
8.3 Therapeutics
8.4 Other Applications
9 Global Human Microbiome Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Seres Therapeutics
11.2 Second Genome Inc.
11.3 Osel Inc.
11.4 Exeliom Biosciences SAS
11.5 Ginkgo Bioworks
11.6 Finch Therapeutics Group Inc.
11.7 Evelo Biosciences Inc
11.8 DuPont
11.9 Axial Biotherapeutics, Inc.
11.10 Astarte Medical
List of Tables
Table 1 Global Human Microbiome Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 4 Global Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 5 Global Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 6 Global Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 7 Global Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 8 Global Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 9 Global Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 10 Global Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 11 Global Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 12 Global Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 13 Global Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 14 Global Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 15 Global Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 16 Global Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 17 Global Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 18 Global Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 19 Global Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 20 Global Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 21 Global Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 22 North America Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 23 North America Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 24 North America Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 25 North America Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 26 North America Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 27 North America Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 28 North America Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 29 North America Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 30 North America Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 31 North America Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 32 North America Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 33 North America Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 34 North America Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 35 North America Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 36 North America Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 37 North America Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 38 North America Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 39 North America Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 40 North America Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 41 North America Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 42 North America Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 43 Europe Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 44 Europe Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 45 Europe Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 46 Europe Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 47 Europe Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 48 Europe Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 49 Europe Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 50 Europe Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 51 Europe Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 52 Europe Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 53 Europe Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 54 Europe Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 55 Europe Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 56 Europe Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 57 Europe Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 58 Europe Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 59 Europe Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 60 Europe Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 61 Europe Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 62 Europe Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 63 Europe Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 64 Asia Pacific Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 65 Asia Pacific Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 66 Asia Pacific Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 67 Asia Pacific Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 68 Asia Pacific Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 69 Asia Pacific Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 70 Asia Pacific Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 71 Asia Pacific Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 72 Asia Pacific Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 73 Asia Pacific Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 74 Asia Pacific Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 75 Asia Pacific Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 76 Asia Pacific Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 77 Asia Pacific Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 78 Asia Pacific Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 79 Asia Pacific Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 80 Asia Pacific Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 81 Asia Pacific Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 82 Asia Pacific Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 83 Asia Pacific Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 84 Asia Pacific Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 85 South America Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 86 South America Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 87 South America Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 88 South America Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 89 South America Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 90 South America Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 91 South America Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 92 South America Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 93 South America Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 94 South America Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 95 South America Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 96 South America Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 97 South America Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 98 South America Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 99 South America Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 100 South America Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 101 South America Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 102 South America Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 103 South America Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 104 South America Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 105 South America Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 106 Middle East & Africa Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 107 Middle East & Africa Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 108 Middle East & Africa Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 109 Middle East & Africa Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 110 Middle East & Africa Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 111 Middle East & Africa Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 112 Middle East & Africa Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 113 Middle East & Africa Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 114 Middle East & Africa Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 115 Middle East & Africa Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 116 Middle East & Africa Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 117 Middle East & Africa Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 118 Middle East & Africa Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 119 Middle East & Africa Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 120 Middle East & Africa Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 121 Middle East & Africa Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 122 Middle East & Africa Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 123 Middle East & Africa Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 124 Middle East & Africa Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 125 Middle East & Africa Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 126 Middle East & Africa Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)

$4,150
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings